Keywords: Stiefel Labs, GlaxoSmithKline, USA, SEC, Shareholders defrauded

SEC says GSK unit CEO defrauded shareholders

Article | 14 December 2011

Print This

The USA’s Securities and Exchange Commission says it has charged a subsidiary of UK pharma giant GlaxoSmithKline (LSE: ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in